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Chapter 1: Introduction
Articular cartilage damage in the knee is a common pathology that can affect a
large range of ages. It is estimated that 63% of patients receiving routine arthroscopies
are found to have articular cartilage defects.4 This type of cartilage has little blood supply;
therefore, repair without surgery is highly unlikely. Surgical options to repair articular
cartilage defects include autologous chondrocyte implantation (ACI), microfracture,
osteochondral autologous transplantation (OATS), and mosaicplasty. However, a gold
standard treatment for articular chondral defects has not been established.8 Given that
ACI is a novel procedure, there is limited data on patient-centered functional outcomes,
and a lack of knowledge of long-term progression in these patients. There is also limited
research providing the appropriate data needed to establish whether this procedure entails
better patient outcomes than other chondral defect surgeries.
Autologous Chondrocyte Implantation (ACI) is a tissue-engineered articular
cartilage repair procedure that patients can undergo to repair damaged articular cartilage.
This is a two-step procedure in which the first surgical procedure involves an
arthroscopic biopsy of healthy articular cartilage that is then sent to a cell expansion
laboratory where the cells are allowed to replicate for 4-6 weeks. After the cartilage has
grown, the second procedure follows and the cartilage is implanted in place of damaged
tissue.
Since this is still a novel procedure, there is no set criterion for whether a patient
should or should not get an ACI. With no predictors of a positive outcome, nor
substantial research indicating success rates, insurance companies are hesitant in
reimbursement. The ability to predict a successful outcome would benefit patients

financially in regards to reimbursement. Insurance companies are moving towards
patient-centered outcomes to review the success of surgical procedures. Determining the
level of reimbursement is based off of the data collected, where higher success rates
reflect more substantial reimbursement. Higher reimbursement rates would mean the
insurance companies would cover more of the rate and require less out of pocket money
from the patient. By using patient-centered outcomes, we can trim physician bias and
obtain personal outcome data from the patient population. This is beneficial because
medicine is progressing toward patient-centered and functional outcomes vs.
objective/surgeon/ clinician-based outcomes. Patient documented success is important as
a true measure of success for surgeons, procedures, and predicting outcomes on future
patients. Knee surgeries are expensive, and financial support from insurance companies is
negatively correlated with the risk of a negative outcome. If data showed patient-oriented
success following the ACI procedure, then insurance and healthcare companies are more
likely to provide more money for the patients.
The purpose of this study was to evaluate patient-centered outcomes of functional
capability and pain levels following ACI surgery, as well as compare results from
previous studies.
Chapter 2: Literature Review
Surveys
When determining the efficacy of a procedure, physiological measures are
important but they do, however, omit the patients’ perception. Surveys allow the
collection of more subjective patient data. This study pertains to patient surveys in the
form of patient-centered outcomes (PCO’s). Appleby describes PCO’s as a measure of

quality that links effectiveness with efficiency of care.18 These outcomes focus on purely
subjective responses that more directly reflect a patients health status than physiological
measures.
Patient-oriented improvement following ACI surgery in this study was evaluated
using the International Knee Documentation Committee (IKDC), global rating of change
scale (GROC), depression self-assessment (DSA) and the visual analog scale for pain
(VAS). The IKDC presents a variety of questions surrounding symptoms, function, and
sports activities that are ranked from 1 to 5 or 1 to 10 point scales. Summing the scores
and dividing by the total possible score establishes an IKDC score. The minimum
clinically important difference for the IKDC is reported to be 6.3 at 6 months and 16.7 at
12 months.12
The global rating of change (GROC) survey represents, on a -7 to +7 scale, the
rate of change in overall functional capability. The lower end of the GROC is “a very
great deal worse,’ while the top is “a very great deal better.” The GROC scale is used to
quantify a patients improvement or deterioration over time usually to determine the effect
of an intervention.13 The Depression Self-assessment (DSA) is a 20-item self reported
instrument that consists of symptom rating scales that provide a measure of depression
symptom frequency and cutoff score indicating a probable diagnosis of depression.16 An
overall score out of 60 is determined with a score over 16 indicating depression. The
VAS pain scale is used to measure pain intensity currently and at the moments where
pain is the worst. These scales are from 0 to 100 mm. Patients with VAS pain scores of
30 mm or less would be categorized as having mild pain, those with scores of 70 mm or
more were categorized as having severe pain and those from 31 mm to 69 mm, moderate

pain.14 The minimal clinically significant difference (MCSD) in VAS pain score was
defined as the mean difference between current and preceding scores when the subject
reported “a little worse” or “a little better” pain.14
ACI procedure
Chondral injuries are debilitating pathologies that can compromise the quality of
life due to pain, swelling, and impaired mechanical movement.6 The chondral tissue
discussed in this study is hyaline cartilage. Hyaline cartilage does not receive an adequate
blood supply to heal, so surgical intervention is often necessary.4 The Autologous
Chondrocyte Implantation (ACI) surgery is a two-stage operation, typically spread out
over a 5 week time period. First, an arthroscopic surgery is performed to obtain 200-300
mg of healthy articular cartilage harvested from a non-weight bearing portion of the
knee.4 The cells are then sent to a tissue-engineering laboratory for chondrocyte
expansion.4 Once approximately10 million cells are collected, the cells are implanted
underneath a periosteum flap obtained from the proximal end of the tibia.7 It has been
shown that a patient following a failed microfracture surgery can benefit greatly from the
ACI procedure because of damage to the subchondral plate.4 It is still unclear whether
realignment procedure performed previous to or with the ACI is detrimental. In a study
comparing the ACI procedure to mosaicplasty, an alternative approach, the ACI patients
had significantly greater outcomes.5
Successful outcomes
Evaluating ACI patients ≥ one year post-operation in overall knee condition, knee
function, and patient symptomatology helps to establish the efficiency of the procedure.
As shown in a study done by Micheli et al,3 84% (42 of 50) of patients were improved 36

months postoperatively and only 6% (3 of 50) had graft failure. Failure of a graft usually
leads to subsequent total knee replacement. Multiple studies have shown that ACI has a
fairly low failure rate. One study with a large patient population (N=827) revealed that
graft survival rate was 78.2% at 5 years and 50.7% at 10 years.11 Another study, PascualGarrido et al,4 found that only 7.7% (4 of 52) ACI grafts resulted in failure. A similar
study of ACI patients age 45 and older recorded a failure rate of 4.9% (3 of 54) in nonworkers compensation patients, and an overall failure rate of 14% (8 of 54).6
Improvements in pain and overall function
Studies have demonstrated that ACI patients typically improve in pain and overall
function of health. One study, of 34 patients, obtained preoperative IKDC scores where
only 8 knees were classified as normal and 26 were classified as abnormal or severely
abnormal.2 After 2 years, 32 of the 34 patients knees were classified as IKDC normal or
nearly normal following the ACI procedure.2 IKDC scores showed significant
improvement in this study. Scores went from 46.09 ± 19.3 preoperatively to 77.06 ± 17.0
2 years after implantation, and then to 70.39 ± 21.4 at 5 years (Figure 1).2

Figure 1. IKDC score: improvement from preoperative to 2 and 5 years’ follow-up.2

Pascual-Garrido et al4 concluded that autologous chondrocyte implantation is a viable
treatment option for chondral defects. This study included 62 patients and examined
preoperative and follow-up (2-5 years) IKDC scores. The mean improvement for IKDC
was 31-57.
Patients who undergo ACI surgery have been shown to experience a decrease in
overall and functional pain levels. Gobbi et al2 reported a preoperative mean EQ VAS
score of 56.75 ± 18 that improved to 81.47 ± 13.3 at 2-year follow-up. Another study
demonstrated similar results with VAS pain levels >60 evident in 64% (32 0f 50) of the
patients preoperatively, but only 4 % (2 of 50) had pain levels >60 at follow-up. 15

Patient satisfaction
One study of 56 patients ≥45 years of age who underwent cartilage repair with
ACI.6 Rosenberger et al6 chose 45 years of age as their threshold because this is the
common insurance age limit for ACI, despite weak supporting data. This study claims
that results are comparable to younger ACI patients when comparing patient satisfaction,
and four validated rating scales: Short Form-36, Modified Cincinnati Rating Scale,
WOMAC Osteoarthritis index, and the Knee Society Score.6 At their latest available
follow-up, 72% of patients rated themselves as good or excellent, 78% felt improved, and
81% would again choose ACI as a treatment option (Table 1).6
Table 1. ACI patient satisfaction at latest follow-up (range, 2-11 years; mean, 4.7 years).6

Microfracture
Microfracture is a surgical substitution for the ACI procedure to revise chondral
defects. Microfracture provides an enriched environment for tissue regeneration on the
chondral surface by using the body's own healing abilities. After damaged cartilage has
been removed, multiple holes are drilled in the exposed bone. Blood and bone marrow
cells seep through and eventually form a clot that matures into firm repair tissue. Many
long-term studies on microfracture have found increased complications compared to
other procedures. Gudas et al10 found that 4 year microfracture postoperative failure rate
was 41% (9 of 22). Microfracture surgery can cause lingering pain and prolonged damage
to the subchondral plate. One study suggests that microfracture surgery may cause
damage to the subchondral plate compromising additional revision surgery.9 Damage to
the subchondral plate suggests the need for a second surgery, like ACI, to revise the
defects.
Chapter 3: Methods
This study included 10 patients, male and female, from a local orthopedic
practice. Subjects were asked to complete a survey packet pre-operatively, and at three,
six, and 12 months post-surgery as part of their standard medical files. These surveys
included the International Knee Documentation Committee (IKDC), Visual Analog Scale
(VAS) for Pain, Depression Self-assessment (DSA), and a Global Rating of Change
(GROC) for overall functional ability. Once IRB approval was obtained, researchers
picked up patient survey packets and entered their data, which was de-identified. The
IKDC survey consists of 9 small surveys; data will be summed to denote a number value
from 0 to 87 and divided by 0.87, representing patient’s knee function. The VAS scale

consists of a current and “when at worst” scale; these values will be collected and
averaged to denote a number value for the patients overall pain level. The DSA is a
survey that asks the patient to read ways they may have felt in the past week, and mark
whether they were feelings lasting less than one day, one to two days, three to four days,
or five-seven days. This data was summed to a value out of 60, where a number above 16
suggests depression. The GROC scale consists of an overall and specific functional
capabilities scale; both values were assessed individually and given a value of -7 to 7. I
reviewed these scores for each patient and entered them into spreadsheet software for
data analysis.
Statistical Analysis
All variables were analyzed with descriptive statistics and percentages of patients
were calculated. Select variables were analyzed using paired samples t-tests. Receiver
operator characteristic curve analysis was conducted to determine cut points for select
variables as potential predictors of successful outcome. To determine clinically relevant
outcomes and predictive value, further 2X2 cross tabulation analysis was used to
calculate sensitivity, specificity, and relative risk ratios.

Chapter 4: Results
The time frame established for short-term success was determined by postoperative surveys, which varied in time (2.7 ± 0.9 months; range: 1-4 months) following
surgery. Patient responses to short-term global rating of change (GROC) varied greatly
(Table 2). Post-operative GROC analysis showed that 8 patients (80%) had at least “a
little better” overall functional capabilities, 1 (10%) had “no change,” and 1 (10%) failed

to respond. Post-operative GROC analysis of specific capabilities showed identical
results with 8 patients (80%) having at least “a little better” overall functional
capabilities, 1 (10%) with “no change,” and 1 (10%) failed to respond.
Pre-operative IKDC scores reported 3 patients as having 10-30% function, 2 with
30-50%, 1 with 50-70%, and 2 with 70-80% function. Post-operative IKDC scores
showed 3 patients as having 10-30% function, 5 with 30-50%, 1 with 50-60%, as well as
1 unreported response. The difference in post-operation and pre-operation IKDC scores
varied from better to worse (Table 3). With 1 failed response, 4 patients (40%) saw
improvements in IKDC scores (range: 4 to 25 points). Five patients (50%) were found to
have a decrease in IKDC scores (range: -1 to -34 points).
Pre-DSA scores ranged from 3-23 with 1 patient considered “depressed” (score
≥16). 8 patients (80%) scored <10, 1 (10%) scored a 12, and 1 (10%) scored a 23.
Current VAS pain scored, pre-operatively, showed a mean pain score of 2.45 ±
1.82 where 7 patients (70%) had pain levels between 0-3 and 3 patients (30%) had levels
between 4-6. Post-operative current VAS scores showed a mean pain level of 1.32 ± 1.13
where all 10 patients scored between 0-3. Short-term pain levels decreased from preoperation by a mean of 1.13 ± SD 2.21. 4 patients (40%) had an increase in pain levels
between 0-1.5 points, 4 (40%) decreased by 1-3 points, and 2 (20%) decreased by 4-5
points.
"At worst" VAS pain levels before surgery averaged 7.6 points ± 1.37 with 4
patients (40%) scoring between 5-7 and 6 (60%) scoring between 8-10. Post-operative "at
worst" averaged 6.15 ± 2.7 points with 4 patients (40%) between 2-4, 2 (20%) between 57, and 4 (40%) between 8-10. Pain, when at its worst, was shown to decrease by a mean

of 1.45 ± 3.05 points with 3 (30%) who experienced an increase in pain between 0-3, 3
(30%) with decreased levels between 0-3, 3 (30%) decreased between 4-7, as well as 1
(10%) with no change.
For the purpose of this study, successful short-term outcomes were established as
a GROC score ≥3 or post-VAS pain levels ≤2. 8 patients (80%) had a successful outcome
determined by GROC score, post-VAS score, or both. There were 8 patients (80%) that
had success via GROC outcome and 5 patients (50%) who had success via VAS pain
score.
Patients with pre-operative VAS scores ≥3 were more likely to have a successful
short-term outcome, via GROC ≥3, with a relative risk of 1.5 (figure 2). Similarly,
reviewing GROC scores ≥3 also showed patients with pre-IKDC scores <50 had more
successful outcomes with a relative risk of 3. Patients with a DSA score >7 were found to
have a 1.56 times greater chance of having a change in rating of function of ≤3 when
compared to those who scored 7 or less on this survey (figure 2).
Patients below the age of 40 were found to have lower pain levels (≤2) more often
than those ≥40 years of age with a relative risk of 1.67 (figure 3). Patients ≥40 had more
successful outcomes, GROC ≥3, than patients below 40 (relative risk 1.8).

Table 2. Patient Global Rating of Change at Short-term Follow-up (range: 1-4 months;
mean: 2.7 months; n=10).
Question
Since first starting treatment, how
would
you rate your change in overall
functional capabilities

Statistic

Response (n=10)

A great deal better
A good deal better
Moderately better
Somewhat better
A little better
Almost the same
No change
No response

0
1 (10%)
2 (20%)
2 (20%)
3 (30%)
0
1 (10%)
1 (10%)

Since first starting treatment, how
would
you rate your change in specific
functional capabilities
A great deal better
1 (10%)
A good deal better
1 (10%)
Moderately better
2 (20%)
Somewhat better
1 (10%)
A little better
2 (20%)
Almost the same
1 (10%)
No change
1 (10%)
No Response
1 (10%)
Table 3. Difference in Post-operation and Pre-operation IKDC scores (range: 1-4
months; mean: 2.7 months; n=10).
Difference in IKDC Score
20 to 30 points

Statistic (n=10)
1 (10%)

10 to 20 points

1 (10%)

0 to 10 points

2 (20%)

-10 to 0 points

3 (30%)

-20 to -10 points

1 (10%)

-30 to -20 points

0

-40 to -30 points

1 (10%)

No response

1 (10%)

Figure 2. Comparing Patient Pre-DSA, Age, and Pre-VAS Data to Short-term GROC
Outcomes.
3.5

Number of Patients

3
2.5
2
GROC≥3

1.5

GROC≤2

1
0.5
0
Pre-DSA ≥8 Pre-DSA ≤7 Age ≥40

Age ≤39 Pre-VAS ≥2 Pre-VAS <2

Survey

Figure 3. Comparing Patients Age and Pre-VAS data to Post-VAS pain scores.
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Chapter 5: Discussion
After analyzing and comparing pre- and post-operative surveys, it is evident that
most patients experienced short-term success. For the purpose of this study, successful
short-term outcomes were established as a GROC score ≥3 or post-VAS pain levels ≤2.
With an 80% success rate, data suggests that the ACI procedure does elicit short-term
success.
Success Rate
Since the complete recovery time for this surgery is 1 year, it must be noted that
these short-term success rates are in a time frame that is only about 33% through postsurgical treatment. The small change in overall function with the GROC scale was
expected because of this. This explains the small decrease in pain levels (mean 1.13) as
well. Patients were enduring intense rehabilitation programs and most are only just
recently off of crutches or still using them. Function was expected to be low and pain
levels can stem from the intense rehab as well.
Possible Predictors
Age, VAS pain scale, IKDC, and DSA scores, pre-operatively, were found to be
possible predictors of a short-term successful outcome. Patients below the age of 40
displayed a 1.67 times greater chance of experiencing pain levels ≤2 during their shortterm follow-up. According to Woodrow et al,17 pain tolerance decreases linearly with
age, so it is relevant that younger patients would record lower pain levels.
Patients 40 years of age or older were shown to have a 1.8 times greater chance of
having a GROC score of ≥3 than those under the age of 40. Older patients generally have

less function overall, so younger patients most likely felt that they had not progressed
much in getting back to their original functional capabilities.
Pre-VAS pain scores suggest that patients with a score of ≥3 pre-operatively will
be 1.5 times more likely to score ≥3 on the GROC survey than those who scored <3.
Patients experiencing more pain pre-surgery seem to be capable of noticing a greater
change in their short-term function than those who had less pain.
Lower functioning patients, via pre-IKDC data, shows that a patient with <50
points is 3 times more likely to have a GROC score of ≥3. Less function pre-surgery
suggests that the patient will have greater improvements in their function overall. If a
patient has a low functional score, then it is understood that they will notice a greater
change in function more than someone with a higher pre-surgical score.
DSA data suggests that a patient with a score >7 will have a 1.56 times greater
chance to have a negative outcome in regards to the GROC scale (≤3). A patient showing
depressive symptoms would generally have a negative outlook on treatment and progress
in functional capabilities. Therefore, a depressed patient would generally see their
progression of function as slower, or less significant than those who are not depressed.
Previous Studies
Success rates in this study support data collected by Micheli et al.3 Eighty-four
percent of patients in his study reported a successful outcome, where an 80% success rate
was reported in this study. This would suggest that throughout recovery from this
operation, patients generally feel that they are progressing and will have a successful
outcome. A decrease in pain levels also aligned with previous studies.

Conclusion
With our small population size and relatively short time frame, data collected
from this study was unable to confidently declare whether the ACI procedure is
successful. However, our evidence shows that most patients see improvements in preoperative function and pain levels in an average of 2.7 months post-op. Data suggests that
patients with pre-VAS ≥3, pre-IKDC <50, and age >40 are most likely to have a
successful outcome in regards to improved overall functional capabilities. Also, it can be
predicted that younger patients (<40) will have a greater chance to have a successful
outcome with a decrease in pain levels. Conversely, a patient with a score of >7 on the
DSA is more likely to have an unsuccessful outcome.
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